期刊文献+

含中药骨金散血清对大鼠成骨细胞OPG、RANKL mRNA表达的影响 被引量:8

Effects of the expressions of serum with Gujinsan on OPG and RANKL mRNA in cultured osteoblasts of rats
下载PDF
导出
摘要 目的:本研究旨在探讨含中药骨金散血清对成骨细胞的增殖及OPG/RANKL系统的影响。方法:6月龄雌性大鼠48只,随机分为假手术组、模型组、骨金散低剂量组和骨金散高剂量组,每组12只,模型组、骨金散低剂量组和骨金散高剂量组大鼠建立去卵巢大鼠骨质疏松的动物模型,4周后低剂量骨金散组和高剂量骨金散组按1.8g/kg和3.6g/kg灌服骨金散,每日一次;模型组和假手术组均每天一次生理盐水灌胃。连续给药8周后处死大鼠,观察骨金散对去卵巢大鼠股骨骨密度的影响,制备含骨金散血清。体外培养成骨细胞,观察含药血清对成骨细胞的增殖和OPG、RANKL mRNA的表达的影响。结果:与假手术组相比,去卵巢大鼠股骨骨密度明显降低(P<0.01),低剂量的骨金散组和高剂量组大鼠股骨骨密度高于去卵巢组(P<0.01)。低剂量的骨金散组和高剂量组血清促进成骨细胞的增殖(P<0.05),升高OPGmRNA表达水平(P<0.01),降低RANKL mRNA的表达水平(P<0.01),使OPGmRNA/RANKLmRNA的表达比值升高(P<0.01)。结论:中药骨金散能增加去势大鼠BMD,促进成骨细胞增殖,增加成骨细胞OPGmRNA表达,降低RANKLmRNA表达,发挥抑制破骨细胞的骨吸收作用,这可能与其治疗骨质疏松的机制有关。 Objective:To establish the animal models of osteoporosis in ovariectomized rats and investigate the effects of the expressions of serum with Gujinsan on proliferation and OPG and RANKL mRNA in cultured osteoblasts of rat. Methods:48 six--month old SD female rats were randomly assigned to two groups, including the ovariectomized group with 36 rats in the group and false operation group with 12 rats in the group. In the ovariectomized group, double ovaries of rats were removed. In the false operation group, some fat around the o- varies on both sides of rats were removed. At 4 weeks after operation, the ovariectomized group were randomly allocated into three groups with 12 rats in each group: the control group, low--dose Gujinsan group, and high --dose Gujinsan group, by drug intervention are as follows. The low--dose Gujinsan group: intragastric ad- ministrated Gujinsan(1.8g/kg per day). The high--dose Gujinsan group: intragastric administrated Gujinsan (3. 6g/kg per day). The rest of groups:intragastric administrated the same amount of normal saline. Two months later, BMD of rat was measured by using double functional X--ray digital bone density meter. The Ef- fects of serum with Gujinsan on cultured osteoblasts proliferation was evaluated by MTT assay, and the mRNA expressions of OPG and RANKL in cultured osteoblasts of rat were measured by RT--PCR. Results: In o- variectomized control group,the BMD were significantly lower than that in false operation group (P 〈 0.01), while compared with ovariectomized control group, BMD of low--dose Gujinsan group and high--dose Gujin- san group increased significantly (P 〈 0. 01). The serum with Gujinsan of low--dose Gujinsan group and high --dose Gujinsan group can promote the cultured osteoblasts proliferation compared with ovariectomized control group (P 〈0. 01). The OPG mRNA expression of the cultured osteoblasts in serum with Gujinsan was upregu- lated while the RANKL mRNA expressions of the cultured osteoblasts in serum with Gujinsan was down regu- lated compared with ovariectomized control group (P 〈 0.01). The serum with Gujinsan increased the expres- sions ratio of OPG mRNA/RANKL mRNA (P 〈 0.01). Conclusion :The Gujinsan can increase BMD in O- variectomized rats, promote the proliferation of osteoblasts, increase the osteoblasts OPG mRNA expression, reduce the expression of the osteoblast RANKLmRNA, increase the expressions ratio of OPG mRNA/RANKL mRNA,play the role in inhibition of osteoclasts to absorb bone tissue, which may be related to the mechanism of the Gujinsan in treating osteoporosis.
出处 《黑龙江医药科学》 2012年第3期4-6,共3页 Heilongjiang Medicine and Pharmacy
基金 黑龙江省教育厅科学技术研究项目 编号:11533073 黑龙江省中医管理局中医药科研计划项目 编号:ZHY08-Z85
关键词 骨金散 骨质疏松 骨密度 骨保护蛋白 去卵巢大鼠 Gujinsan osteoprotegerin (OPG) Receptor Activator of Nuclear Factor--kB Ligand (RAN- KL) osteoblasts ovariectomized osteoporosis
  • 相关文献

参考文献10

二级参考文献30

  • 1杨力,蔡德鸿,汤灵丽.绝经后骨质疏松与IGF-1及相关骨代谢指标关系的研究[J].广东医学,2005,26(5):624-626. 被引量:10
  • 2Lozo P, Krpan D, krvavica A, et al. Bone histology in post- menopausal osteoporosis variations in celly activity[J]. Act MED Croatica, 2004.58 (1) : 5-11.
  • 3Inanir A,Ozoran K,Tutkak H,et al. The effeets of calcitriol therapy on serurn interleukin 1,interleukin 6 and turnout necrosis factor --alpha concentrations in postmenopausal patients with osteoporosis [J] J Int Med Res,2004,32(6)~570-582.
  • 4Desai MP,Bhanuprakash KV , Khatkhatay Ml,et al. Age-- related changes in bone turnover markers and ovarian hormones in pre- menopausal and postmenopausal Indian women[J]. J Clin Lab Anal, 2007,21(2) :55-60.
  • 5Amelio P,Grimaldi A,Pescarmona Gp,et al. Spontaneous osteoclast formation from peripheral blood mononuclear cells in post- menopausal osteoporosis[J]. Faseb J, 2005,19(3) :410-412.
  • 6Nakamura T, Imai Y, Matsumoto T, et al. Estrogen Prevents Bone Loss via Estrogen Receptor alpha and Induction of Fas Ligand in Osteoclasts[J ]. Cell, 2007,130 (5) : 811-823.
  • 7Hong L,Colpan A,1A. Modulations of 17-beta estradiol on os- teogenic and adipogenic differentiations of human mesenchymal stem cells[J]. Tissue Eng,2006,12(10) :2747-2453.
  • 8Mann V,Huber C,Kogianni G,et al. The antioxidant effect of es- trogen and Selective Estrogen Receptor Modulators in the inhibi- tion of osteocyte apoptosis in vitro[J]. Bone, 2007,40(3) :674-684.
  • 9Clemens JD, Herriek MM, Singer FR, et al. Evidence that serum NTx(cross linked N--telopeptide)can act as an Immunochemical marker of bone resorption[J]. Clin Chem, 1997,43 : 2058-2063.
  • 10Zhao W,Byrne MH,Wang Y,et al. Osteocyte and osteoblast apop- to,sis and excessive bone deposition accompany failure of collagenase cleavage of collagen[J]. J Clin Invest, 2000, 106 : 941-949.

共引文献42

同被引文献119

引证文献8

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部